| Financial Year |
March 31 2023 |
| Monetary Funds |
300,646,647.26 |
| Held-for-trading Financial Assets |
266,364,894.21 |
| Notes Receivable |
87,812,500.00 |
| Accounts Receivable |
193,959,944.59 |
| Advances to Suppliers |
41,955,355.42 |
| Other Receivables |
8,225,862.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,055.00 |
| Dividend Receivable |
1,852,766.21 |
| Inventories |
48,413,869.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,704,272.64 |
| Total Current Assets |
958,083,345.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
101,140,208.87 |
| Investment Properties |
1,039,195,653.85 |
| Fixed Assetes |
88,117,395.22 |
| Under-construction Projects |
124,844.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,290,880.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,346,223.03 |
| Deferred Income Tax Assets |
8,518,233.77 |
| Other Non-Current Assets |
157,861,755.99 |
| Sub-Total of Non-Current Assets |
1,438,550,200.78 |
| Total Assets |
2,396,633,546.19 |
| Short-Term Loans |
70,000,000.00 |
| Trading Financial liabilities |
26,347,500.00 |
| Notes Payable |
-- |
| Accounts Payable |
168,405,291.11 |
| Accounts Received In Advance |
34,052,659.81 |
| Employee Compensation Payable |
34,597,857.77 |
| Taxes Payable |
22,059,934.56 |
| Interest Payable |
299,512.32 |
| Dividend Payable |
-- |
| Other payables |
111,710,905.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,065,889.79 |
| Other Current Liabilities |
67,897,214.51 |
| Sub-Total of Current Liabilities |
543,897,596.31 |
| Long-term Loans |
169,197,969.69 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,924,740.22 |
| Special Payable |
-- |
| Estimatied Liabilities |
268,414.80 |
| Deferred Income Tax Liabilities |
1,135,031.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
186,943,306.63 |
| Total Liabilities |
730,840,902.94 |
| Paid-In Capital(Or Share Stock) |
431,058,320.00 |
| Capital Surplus |
431,449,554.51 |
| Surplus Reserve |
52,499,172.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
615,879,479.52 |
| Minority Stockholder's Interest |
134,879,695.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,530,912,948.16 |
| Owner's Equity（Stockholder's Equity） |
1,665,792,643.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,396,633,546.19 |
